162 related articles for article (PubMed ID: 28192530)
1. Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study.
Neelofar K; Arif Z; Ahmad J; Alam K
PLoS One; 2017; 12(2):e0172074. PubMed ID: 28192530
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the impact of glucosylation on human serum albumin: A multi-technique approach.
Neelofar KM; Ahmad J; Arif Z; Alam K
Int J Biol Macromol; 2016 Nov; 92():881-891. PubMed ID: 27492562
[TBL] [Abstract][Full Text] [Related]
3. An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.
Neelofar K; Ahmad J
Glycoconj J; 2017 Oct; 34(5):575-584. PubMed ID: 28812216
[TBL] [Abstract][Full Text] [Related]
4. Methylglyoxal mediated glycation leads to neo-epitopes generation in fibrinogen: Role in the induction of adaptive immune response.
Rehman S; Alouffi S; Faisal M; Qahtan AA; Alatar AA; Ahmad S
Int J Biol Macromol; 2021 Apr; 175():535-543. PubMed ID: 33529635
[TBL] [Abstract][Full Text] [Related]
5. Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus.
Raghav A; Ahmad J; Alam K
PLoS One; 2017; 12(5):e0176970. PubMed ID: 28520799
[TBL] [Abstract][Full Text] [Related]
6. Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus.
Arif B; Ashraf JM; Moinuddin ; Ahmad J; Arif Z; Alam K
Arch Biochem Biophys; 2012 Jun; 522(1):17-25. PubMed ID: 22516656
[TBL] [Abstract][Full Text] [Related]
7. Glycation of hemoglobin leads to the immunogenicity as a result of neo-epitope generation.
Siddiqui Z; Faisal M; Alatar AA; Ahmad S
Int J Biol Macromol; 2019 Feb; 123():427-435. PubMed ID: 30445080
[TBL] [Abstract][Full Text] [Related]
8. Neo-epitopes on methylglyoxal modified human serum albumin lead to aggressive autoimmune response in diabetes.
Jyoti ; Mir AR; Habib S; Siddiqui SS; Ali A; Moinuddin
Int J Biol Macromol; 2016 May; 86():799-809. PubMed ID: 26861824
[TBL] [Abstract][Full Text] [Related]
9. Fructosylation generates neo-epitopes on human serum albumin.
Allarakha S; Ahmad P; Ishtikhar M; Zaheer MS; Siddiqi SS; Moinuddin ; Ali A
IUBMB Life; 2015 May; 67(5):338-47. PubMed ID: 25914162
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients.
Vay D; Vidali M; Allochis G; Cusaro C; Rolla R; Mottaran E; Bellomo G; Albano E
Diabetologia; 2000 Nov; 43(11):1385-8. PubMed ID: 11126407
[TBL] [Abstract][Full Text] [Related]
11. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process.
Ansari NA; Moinuddin ; Alam K; Ali A
Hum Immunol; 2009 Jun; 70(6):417-24. PubMed ID: 19332092
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against gluco-oxidatively modified human serum albumin detected in diabetes-associated complications.
Khan MW; Qadrie ZL; Khan WA
Int Arch Allergy Immunol; 2010; 153(2):207-14. PubMed ID: 20413989
[TBL] [Abstract][Full Text] [Related]
13. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.
Schalkwijk CG; Ligtvoet N; Twaalfhoven H; Jager A; Blaauwgeers HG; Schlingemann RO; Tarnow L; Parving HH; Stehouwer CD; van Hinsbergh VW
Diabetes; 1999 Dec; 48(12):2446-53. PubMed ID: 10580435
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE.
Al-Shobaili HA; Al Robaee AA; Alzolibani AA; Rasheed Z
Dis Markers; 2012; 33(1):19-34. PubMed ID: 22710866
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to human albumin epitopes in type 1 (insulin-dependent) diabetes mellitus.
Mangili R; Viberti GC; Vergani D
Diabetologia; 1988 Sep; 31(9):639-46. PubMed ID: 2466725
[TBL] [Abstract][Full Text] [Related]
16. Preferential recognition of advanced glycation end products by serum antibodies and low-grade systemic inflammation in diabetes mellitus and its complications.
Raghav A; Ahmad J; Alam K
Int J Biol Macromol; 2018 Oct; 118(Pt B):1884-1891. PubMed ID: 30009900
[TBL] [Abstract][Full Text] [Related]
17. Anti-glycating and anti-cytotoxic effect of silibinin on albumin at early glycation: A physiochemical study.
Neelofar K; Haneef J; Ahmad J; Alam K; Zaidi R
Arch Biochem Biophys; 2024 Mar; 753():109916. PubMed ID: 38296016
[TBL] [Abstract][Full Text] [Related]
18. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
[TBL] [Abstract][Full Text] [Related]
19. Preferential recognition of epitopes on AGE-IgG by the autoantibodies in rheumatoid arthritis patients.
Ahmad S; Habib S; Moinuddin ; Ali A
Hum Immunol; 2013 Jan; 74(1):23-7. PubMed ID: 23073292
[TBL] [Abstract][Full Text] [Related]
20. Neo-Epitopes Generated on Hydroxyl Radical Modified GlycatedIgG Have Role in Immunopathology of Diabetes Type 2.
Islam S; Mir AR; Raghav A; Khan F; Alam K; Ali A; Uddin M
PLoS One; 2017; 12(1):e0169099. PubMed ID: 28046123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
